Financhill
Sell
50

IMTX Quote, Financials, Valuation and Earnings

Last price:
$5.00
Seasonality move :
18.26%
Day range:
$4.69 - $4.90
52-week range:
$3.30 - $13.77
Dividend yield:
0%
P/E ratio:
43.92x
P/S ratio:
3.16x
P/B ratio:
0.99x
Volume:
314.1K
Avg. volume:
771.4K
1-year change:
-51.2%
Market cap:
$591.9M
Revenue:
$168.7M
EPS (TTM):
$0.11

Analysts' Opinion

  • Consensus Rating
    Immatics NV has received a consensus rating of Buy. The company's average rating is a Buy based on 6 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
  • Price Target Upside
    According to analysts' consensus price target of $15.30, Immatics NV has an estimated upside of 214.17% from its current price of $4.87.
  • Price Target Downside
    According to analysts, the lowest downside price target is $9.50 representing 100% downside risk from its current price of $4.87.

Fair Value

  • According to the consensus of 6 analysts, Immatics NV has 214.17% upside to fair value with a price target of $15.30 per share.

IMTX vs. S&P 500

  • Over the past 5 trading days, Immatics NV has overperformed the S&P 500 by 11.19% suggesting its relative strength compared to the major market average is strong at this time.

Share Buyback

  • Immatics NV does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Immatics NV has grown year-over-year revenues for 2 quarters straight. In the most recent quarter Immatics NV reported revenues of $60M.

Earnings Growth

  • Immatics NV has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Immatics NV reported earnings per share of $0.46.
Enterprise value:
-37M
EV / Invested capital:
--
Price / LTM sales:
3.16x
EV / EBIT:
-1.58x
EV / Revenue:
-0.22x
PEG ratio (5yr expected):
--
EV / Free cash flow:
0.20x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
-1.01x
Gross Profit (TTM):
--
Return On Assets:
2.37%
Net Income Margin (TTM):
9.29%
Return On Equity:
3.71%
Return On Invested Capital:
3.71%
Operating Margin:
1.61%
Trailing 12 Months Fiscal Quarters
Period Ending 2022-12-31 2023-12-31 2024-12-31 2023-12-31 2024-12-31
Income Statement
Revenue $187.5M $58.5M $168.6M $17.1M $60M
Gross Profit -- -- -- -- --
Operating Income $37.1M -$110.1M -$41.7M -$29.8M $962.6K
EBITDA $59.7M -$96.3M $36.6M -$26M $49.7M
Diluted EPS $0.57 -$1.28 $0.11 -$0.30 $0.46
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Balance Sheet
Current Assets $293.9M $172.3M $404.5M $496.7M $655.1M
Total Assets $313.2M $197.7M $437.3M $563.7M $724.4M
Current Liabilities $95.3M $107.7M $114.2M $173.1M $70.7M
Total Liabilities $205.7M $170.5M $219.3M $323.2M $126.2M
Total Equity $107.5M $27.2M $218.1M $240.6M $598.2M
Total Debt -- -- -- -- --
Trailing 12 Months Fiscal Quarters
Period Ending 2022-12-31 2023-12-31 2024-12-31 2023-12-31 2024-12-31
Cash Flow Statement
Cash Flow Operations $105.6M $19.7M -$171M $86M -$61.6M
Cash From Investing -$221.2M -$34M -$164.9M $65.2M -$49.5M
Cash From Financing $130.5M $91.5M $346M -$1.6M $155.4M
Free Cash Flow $99M -$13.8M -$188.9M $76.1M -$63.2M
IMTX
Sector
Market Cap
$591.9M
$34.9M
Price % of 52-Week High
35.37%
44.35%
Dividend Yield
0%
0%
Shareholder Yield
-42.96%
-0.82%
1-Year Price Total Return
-51.2%
-38.5%
Beta (5-Year)
0.852
0.738
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years

Technicals

8-day SMA
Buy
Level $4.52
200-day SMA
Sell
Level $8.08
Bollinger Bands (100)
Sell
Level 4.23 - 6.71
Chaikin Money Flow
Sell
Level -41.2M
20-day SMA
Buy
Level $4.19
Relative Strength Index (RSI14)
Buy
Level 59.67
ADX Line
Buy
Level 15.62
Williams %R
Sell
Level -2.069
50-day SMA
Buy
Level $4.49
MACD (12, 26)
Buy
Level 0.04
25-day Aroon Oscillator
Sell
Level -28
On Balance Volume
Neutral
Level 45.9M

Financial Scores

Buy
Altman Z-Score (Annual)
Level (4.2329)
Buy
CA Score (Annual)
Level (0.4994)
--
Beneish M-Score (Annual)
Level (--)
Sell
Momentum Score
Level (2)
Buy
Ohlson Score
Level (-6.6647)
--
Piotroski F Score (Annual)
Level (--)
--
Quality Ratio Score
Level (--)
Sell
Fundamental Score
Level (3)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Immatics NV is a biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies.

Stock Forecast FAQ

In the current month, IMTX has received 6 Buy ratings 0 Hold ratings, and 0 Sell ratings. The IMTX average analyst price target in the past 3 months is $15.30.

  • Where Will Immatics NV Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Immatics NV share price will rise to $15.30 per share over the next 12 months.

  • What Do Analysts Say About Immatics NV?

    Analysts are divided on their view about Immatics NV share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Immatics NV is a Sell and believe this share price will drop from its current level to $9.50.

  • What Is Immatics NV's Price Target?

    The price target for Immatics NV over the next 1-year time period is forecast to be $15.30 according to 6 Wall Street analysts, 6 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.

  • Is IMTX A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Immatics NV is a Buy. 6 of 6 analysts rate the stock a Buy at this time.

  • How Can I Buy Shares Of IMTX?

    You can purchase shares of Immatics NV via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Immatics NV shares.

  • What Is The Immatics NV Share Price Today?

    Immatics NV was last trading at $5.00 per share. This represents the most recent stock quote for Immatics NV. Yesterday, Immatics NV closed at $4.87 per share.

  • How To Buy Immatics NV Stock Online?

    In order to purchase Immatics NV stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Vertex Stock Still a Good Buy?
Is Vertex Stock Still a Good Buy?

Over the past ten years or so, Vertex Pharmaceuticals (NASDAQ:…

Is Okta Stock Finally Gaining Investor Confidence?
Is Okta Stock Finally Gaining Investor Confidence?

Given how digital transformation has proliferated, cyberattacks have also been…

Is The Trade Desk the Best Advertising Stock Now?
Is The Trade Desk the Best Advertising Stock Now?

The worldly backdrop is now shrouded in heavy uncertainty and…

Stock Ideas

Buy
59
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Buy
58
Is MSFT Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 33x

Buy
55
Is NVDA Stock a Buy?

Market Cap: $2.7T
P/E Ratio: 37x

Alerts

Buy
85
HIMS alert for Apr 30

Hims & Hers Health [HIMS] is down 5.48% over the past day.

Buy
54
EAT alert for Apr 30

Brinker International [EAT] is down 1.82% over the past day.

Sell
16
NSP alert for Apr 30

Insperity [NSP] is down 3.3% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock